Advertisement

Cognitive Impairment in the Aging Dialysis and Chronic Kidney Disease Populations: An Occult Burden

  • Anne M. Murray
    Correspondence
    Address correspondence to Anne M. Murray, MD, MSc, Chronic Disease Research Group, 914 South 8th Street, Suite S-406, Minneapolis, MN 55404.
    Affiliations
    Department of Medicine, Geriatrics Division, Hennepin County Medical Center, Minneapolis, MN; Departments of Medicine and Neurology, University of Minnesota, Minneapolis, MN; and Minneapolis Medical Research Foundation, Chronic Disease Research Group, Minneapolis, MN
    Search for articles by this author
      The high burden of cognitive impairment in hemodialysis and chronic kidney disease (CKD) patients has only recently become recognized. Up to 70% of hemodialysis patients aged 55 years and older have moderate to severe chronic cognitive impairment, yet it is largely undiagnosed. Recent studies describe the strong graded relation between estimated glomerular filtration rate and cognitive function in CKD patients. The process of conventional hemodialysis may induce recurrent episodes of acute cerebral ischemia, which, in turn, may contribute to acute decline in cognitive function during dialysis. Thus, the worst time to communicate with dialysis patients may be during the hemodialysis session. Both symptomatic and occult, subclinical ischemic cerebrovascular disease appears to play a large role in a proposed model of accelerated vascular cognitive impairment in these populations. Severe cognitive impairment or dementia among hemodialysis patients is associated with an approximately 2-fold increased risk of both mortality and dialysis withdrawal. Predialysis cognitive screening and adding dementia to the list of comorbidities on Form 2728 would provide critical information regarding the benefit versus risks of receiving dialysis. It could also improve quality of care and outcomes by raising clinicians' awareness of the potential effects of cognitive impairment on medication, fluid, and dietary compliance and the ability to make advance directive decisions among dialysis patients. Although much remains to be learned regarding the pathophysiology of cognitive impairment in kidney disease, the public health implications of this substantial burden are immediate.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pereira A.A.
        • Weiner D.E.
        • Scott T.
        • et al.
        Cognitive function in dialysis patients.
        Am J Kidney Dis. 2005; 45: 448-462
        • Murray A.M.
        • Tupper D.E.
        • Knopman D.S.
        • et al.
        Cognitive impairment in hemodialysis patients is common.
        Neurology. 2006; 67: 216-223
      1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders (ed 4).
        American Psychiatric Association, Washington, DC1994 (pp 124–133)
        • Nissenson A.R.
        • Marsh J.T.
        • Brown W.S.
        • et al.
        Central nervous system function in dialysis patients: A practical approach.
        Semin Dial. 1991; 4: 115-123
        • Gilli P.
        • De Bastiani P.
        Cognitive function and regular dialysis treatment.
        Clin Nephrol. 1983; 19: 188-192
        • Pliskin N.H.
        • Yurk H.M.
        • Ho L.T.
        • et al.
        Neurocognitive function in chronic hemodialysis patients.
        Kidney Int. 1996; 49: 1435-1440
        • Ratner D.P.
        • Adams K.M.
        • Levin N.W.
        • et al.
        Effects of hemodialysis on the cognitive and sensory-motor functioning of the adult chronic hemodialysis patient.
        J Behav Med. 1983; 6: 291-311
        • Ryan J.J.
        • Souheaver G.T.
        • DeWolfe A.S.
        Intellectual deficit in chronic renal failure. A comparison with neurological and medical-psychiatric patients.
        J Nerv Ment Dis. 1980; 168: 763-767
        • Sehgal A.R.
        • Grey S.F.
        • DeOreo P.B.
        • et al.
        Prevalence, recognition, and implications of mental impairment among hemodialysis patients.
        Am J Kidney Dis. 1997; 30: 41-49
        • Kurella M.
        • Chertow G.M.
        • Luan J.
        • et al.
        Cognitive impairment in chronic kidney disease.
        J Am Geriatr Soc. 2004; 52: 1863-1869
        • Kurella M.
        • Yaffe K.
        • Shlipak M.G.
        • et al.
        Chronic kidney disease and cognitive impairment in menopausal women.
        Am J Kidney Dis. 2005; 45: 66-76
        • Hailpern S.M.
        • Melamed M.L.
        • Cohen H.W.
        • et al.
        Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).
        J Am Soc Nephrol. 2007; 18: 2205-2213
        • Seliger S.L.
        • Siscovick D.S.
        • Stehman-Breen C.O.
        • et al.
        Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study.
        J Am Soc Nephrol. 2004; 15: 1904-1911
      2. United States Renal Data System: USRDS 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2006
      3. United States Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2005
        • Kurella M.
        • Mapes D.L.
        • Port F.K.
        • et al.
        Correlates and outcomes of dementia among dialysis patients: The Dialysis Outcomes and Practice Patterns Study.
        Nephrol Dial Transplant. 2006; 21: 2543-2548
        • Hendrie H.C.
        • Murrell J.
        • Gao S.
        • et al.
        International studies in dementia with particular emphasis on populations of African origin.
        Alzheimer Dis Assoc Disord. 2006; 20: S42-S46
        • Posner H.B.
        • Tang M.X.
        • Luchsinger J.
        • et al.
        The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.
        Neurology. 2002; 58: 1175-1181
        • Knopman D.
        • Boland L.L.
        • Mosley T.
        • et al.
        Cardiovascular risk factors and cognitive decline in middle-aged adults.
        Neurology. 2001; 56: 42-48
        • Arvanitakis Z.
        • Wilson R.S.
        • Bienias J.L.
        • et al.
        Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
        Arch Neurol. 2004; 61: 661-666
      4. Solomon A, Kareholt I, Ngandu T, et al: Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging, in press

        • Barberger-Gateau P.
        • Raffaitin C.
        • Letenneur L.
        • et al.
        Dietary patterns and risk of dementia: The three-city cohort study.
        Neurology. 2007; 69: 1921-1930
        • Qiu C.
        • De Ronchi D.
        • Fratiglioni L.
        The epidemiology of the dementias: An update.
        Curr Opin Psychiatry. 2007; 20: 380-385
        • Gorelick P.B.
        Risk factors for vascular dementia and Alzheimer disease.
        Stroke. 2004; 35: 2620-2622
        • Murray A.M.
        • Pederson S.L.
        • Tupper D.E.
        • et al.
        Acute variation in cognitive function in hemodialysis patients: A cohort study with repeated measures.
        Am J Kidney Dis. 2007; 50: 270-278
        • Kurella M.
        • Chertow G.M.
        • Fried L.F.
        • et al.
        Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study.
        J Am Soc Nephrol. 2005; 16: 2127-2133
        • Seshadri S.
        • Beiser A.
        • Selhub J.
        • et al.
        Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
        N Engl J Med. 2002; 346: 476-483
        • Savazzi G.M.
        • Cusmano F.
        • Vinci S.
        • et al.
        Progression of cerebral atrophy in patients on regular hemodialysis treatment: Long-term follow-up with cerebral computed tomography.
        Nephron. 1995; 69: 29-33
        • Merkus M.P.
        • Jager K.J.
        • Dekker F.W.
        • et al.
        Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The Necosad Study Group.
        Am J Kidney Dis. 1997; 29: 584-592
        • Neto J.F.
        • Ferraz M.B.
        • Cendoroglo M.
        • et al.
        Quality of life at the initiation of maintenance dialysis treatment—A comparison between the SF-36 and the KDQ questionnaires.
        Qual Life Res. 2000; 9: 101-107
        • Smith C.
        • Silva-Gane M.
        • Chandna S.
        • et al.
        Choosing not to dialyse: Evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure.
        Nephron Clin Pract. 2003; 95: c40-c46
        • Casserly I.
        • Topol E.
        Convergence of atherosclerosis and Alzheimer's disease: Inflammation, cholesterol, and misfolded proteins.
        Lancet. 2004; 363: 1139-1146
        • Seliger S.L.
        • Gillen D.L.
        • Longstreth Jr., W.T.
        • et al.
        Elevated risk of stroke among patients with end-stage renal disease.
        Kidney Int. 2003; 64: 603-609
        • Ivan C.S.
        • Seshadri S.
        • Beiser A.
        • et al.
        Dementia after stroke: The Framingham Study.
        Stroke. 2004; 35: 1264-1268
        • Seliger S.L.
        • Sarnak M.J.
        Subclinical vascular disease of the brain in dialysis patients.
        Am J Kidney Dis. 2007; 50: 8-10
        • Bernick C.
        • Kuller L.
        • Dulberg C.
        • et al.
        Silent MRI infarcts and the risk of future stroke: The cardiovascular health study.
        Neurology. 2001; 57: 1222-1229
        • Vermeer S.E.
        • Den Heijer T.
        • Koudstaal P.J.
        • et al.
        Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.
        Stroke. 2003; 34: 392-396
        • Seliger S.L.
        • Longstreth Jr., W.T.
        • Katz R.
        • et al.
        Cystatin C and subclinical brain infarction.
        J Am Soc Nephrol. 2005; 16: 3721-3727
        • Nakatani T.
        • Naganuma T.
        • Uchida J.
        • et al.
        Silent cerebral infarction in hemodialysis patients.
        Am J Nephrol. 2003; 23: 86-90
        • Schmidt W.P.
        • Roesler A.
        • Kretzschmar K.
        • et al.
        Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population.
        J Am Geriatr Soc. 2004; 52: 1045-1050
        • Naganuma T.
        • Uchida J.
        • Tsuchida K.
        • et al.
        Silent cerebral infarction predicts vascular events in hemodialysis patients.
        Kidney Int. 2005; 67: 2434-2439
        • Fernando M.S.
        • Simpson J.E.
        • Matthews F.
        • et al.
        White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury.
        Stroke. 2006; 37: 1391-1398
        • Sachdev P.S.
        • Brodaty H.
        • Valenzuela M.J.
        • et al.
        The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients.
        Neurology. 2004; 62: 912-919
        • Martinez-Vea A.
        • Salvado E.
        • Bardaji A.
        • et al.
        Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
        Am J Kidney Dis. 2006; 47: 241-250
        • Fazekas G.
        • Fazekas F.
        • Schmidt R.
        • et al.
        Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment.
        J Neurol Sci. 1995; 134: 83-88
        • Savazzi G.M.
        • Cusmano F.
        • Musini S.
        Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis.
        Nephron. 2001; 89: 31-36
        • Agildere A.M.
        • Kurt A.
        • Yildirim T.
        • et al.
        MRI of neurologic complications in end-stage renal failure patients on hemodialysis: Pictorial review.
        Eur Radiol. 2001; 11: 1063-1069
        • Kim C.D.
        • Lee H.J.
        • Kim D.J.
        • et al.
        High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis.
        Am J Kidney Dis. 2007; 50: 98-107
        • Breteler M.M.
        • van Amerongen N.M.
        • van Swieten J.C.
        • et al.
        Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study.
        Stroke. 1994; 25: 1109-1115
        • Longstreth Jr., W.T.
        • Manolio T.A.
        • Arnold A.
        • et al.
        Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.
        Stroke. 1996; 27: 1274-1282
        • Inouye S.K.
        Delirium in older persons.
        N Engl J Med. 2006; 354: 1157-1165
        • Levkoff S.E.
        • Evans D.A.
        • Liptzin B.
        • et al.
        Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients.
        Arch Intern Med. 1992; 152: 334-340
        • Murray A.M.
        • Levkoff S.E.
        • Wetle T.T.
        • et al.
        Acute delirium and functional decline in the hospitalized elderly patient.
        J Gerontol. 1993; 48: M181-M186
        • Kiely D.K.
        • Bergmann M.A.
        • Jones R.N.
        • et al.
        Characteristics associated with delirium persistence among newly admitted post-acute facility patients.
        J Gerontol A Biol Sci Med Sci. 2004; 59: 344-349
        • Schor J.D.
        • Levkoff S.E.
        • Lipsitz L.A.
        • et al.
        Risk factors for delirium in hospitalized elderly.
        JAMA. 1992; 267: 827-831
        • Inouye S.K.
        • Ferrucci L.
        Elucidating the pathophysiology of delirium and the interrelationship of delirium and dementia.
        J Gerontol A Biol Sci Med Sci. 2006; 61: 1277-1280
        • Arieff A.I.
        Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention.
        Kidney Int. 1994; 45: 629-635
        • Stefanidis I.
        • Bach R.
        • Mertens P.R.
        • et al.
        Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery.
        Clin Nephrol. 2005; 64: 129-137
        • Ramlawi B.
        • Rudolph J.L.
        • Mieno S.
        • et al.
        C-reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery.
        Surgery. 2006; 140: 221-226
        • Ramlawi B.
        • Rudolph J.L.
        • Mieno S.
        • et al.
        Serologic markers of brain injury and cognitive function after cardiopulmonary bypass.
        Ann Surg. 2006; 244: 593-601
        • Lewis E.G.
        • O'Neill W.M.
        • Dustman R.E.
        • et al.
        Temporal effects of hemodialysis on measures of neural efficiency.
        Kidney Int. 1980; 17: 357-363
        • Wardlaw J.M.
        • Sandercock P.A.
        • Dennis M.S.
        • et al.
        Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?.
        Stroke. 2003; 34: 806-812
      5. Farrall AJ, Wardlaw JM: Blood-brain barrier: Ageing and microvascular disease—Systematic review and meta-analysis. Neurobiol Aging, in press

        • Wardlaw J.M.
        • Lewis S.C.
        • Keir S.L.
        • et al.
        Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions.
        Stroke. 2006; 37: 2633-2636
        • Bowman G.L.
        • Kaye J.A.
        • Moore M.
        • et al.
        Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.
        Neurology. 2007; 68: 1809-1814
        • Ikram M.K.
        • de Jong F.J.
        • Van Dijk E.J.
        • et al.
        Retinal vessel diameters and cerebral small vessel disease: The Rotterdam Scan Study.
        Brain. 2006; 129: 182-188
        • Ikram M.K.
        • de Jong F.J.
        • Bos M.J.
        • et al.
        Retinal vessel diameters and risk of stroke: The Rotterdam Study.
        Neurology. 2006; 66: 1339-1343
        • Longstreth Jr., W.
        • Larsen E.K.
        • Klein R.
        • et al.
        Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: The Cardiovascular Health Study.
        Am J Epidemiol. 2007; 165: 78-84
        • Wada M.
        • Nagasawa H.
        • Kurita K.
        • et al.
        Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects.
        J Neurol Sci. 2007; 255: 27-34
        • Cao J.J.
        • Barzilay J.I.
        • Peterson D.
        • et al.
        The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study.
        Atherosclerosis. 2006; 187: 372-377
        • Englund E.
        Neuropathology of white matter lesions in vascular cognitive impairment.
        Cerebrovasc Dis. 2002; 13 (suppl 2): 11-15
        • Walsh D.M.
        • Klyubin I.
        • Shankar G.M.
        • et al.
        The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
        Biochem Soc Trans. 2005; 33: 1087-1090
        • Toyoda K.
        • Fujii K.
        • Fujimi S.
        • et al.
        Stroke in patients on maintenance hemodialysis: A 22-year single-center study.
        Am J Kidney Dis. 2005; 45: 1058-1066
        • Mizumasa T.
        • Hirakata H.
        • Yoshimitsu T.
        • et al.
        Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: A 3-year prospective study.
        Nephron Clin Pract. 2004; 97: c23-c30
        • Gottlieb D.
        • Mildworf B.
        • Rubinger D.
        • et al.
        The regional cerebral blood flow in patients under chronic hemodialytic treatment.
        J Cereb Blood Flow Metab. 1987; 7: 659-661
        • Postiglione A.
        • Faccenda F.
        • Gallotta G.
        • et al.
        Changes in middle cerebral artery blood velocity in uremic patients after hemodialysis.
        Stroke. 1991; 22: 1508-1511
        • Hata R.
        • Matsumoto M.
        • Handa N.
        • et al.
        Effects of hemodialysis on cerebral circulation evaluated by transcranial Doppler ultrasonography.
        Stroke. 1994; 25: 408-412
        • Ishida I.
        • Hirakata H.
        • Sugimori H.
        • et al.
        Hemodialysis causes severe orthostatic reduction in cerebral blood flow velocity in diabetic patients.
        Am J Kidney Dis. 1999; 34: 1096-1104
        • Kanai H.
        • Hirakata H.
        • Nakane H.
        • et al.
        Depressed cerebral oxygen metabolism in patients with chronic renal failure: A positron emission tomography study.
        Am J Kidney Dis. 2001; 38: S129-S133
        • Jassal S.V.
        • Devins G.M.
        • Chan C.T.
        • et al.
        Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot study.
        Kidney Int. 2006; 70: 956-962
        • Rakowski D.A.
        • Caillard S.
        • Agodoa L.Y.
        • et al.
        Dementia as a predictor of mortality in dialysis patients.
        Clin J Am Soc Nephrol. 2006; 1: 1000-1005
        • Murray A.M.
        • Arko C.
        • Chen S.C.
        • et al.
        Use of hospice in the United States dialysis population.
        Clin J Am Soc Nephrol. 2006; 1: 1248-1255
        • Sarkisian C.A.
        • Lachs M.S.
        “Failure to thrive” in older adults.
        Ann Intern Med. 1996; 124: 1072-1078